Founded in Durham, North Carolina, BioSkryb Genomics is dedicated to revolutionizing single cell molecular discovery and analysis. The company's core mission is to provide advanced genomic tools that enable scientists and clinicians to gain a comprehensive understanding of the genome, transcriptome, and proteome within individual cells. Their primary products include single cell whole genome and whole transcriptome amplification tools, which are pivotal for advancing research in complex disease mechanisms and management.
BioSkryb Genomics has garnered attention from notable investors and industry leaders, contributing to its rapid growth and innovation in the field. The company's cutting-edge technologies have significantly impacted genomic research, providing unprecedented insights into cellular functions and disease pathways. Through their pioneering efforts, BioSkryb Genomics continues to shape the future of molecular biology and personalized medicine.
